Evidence map›Paper›PMID 32106533›Full record

ArticleMolecules (Basel, Switzerland)2020

Tepary Bean (

Ulisses Moreno-Celis, F Josué López-Martínez, Ricardo Cervantes-Jiménez, Roberto Augusto Ferríz-Martínez, Alejandro Blanco-Labra, Teresa García-Gasca

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. Pharmaceuticals (Basel, Switzerland) · 2025
    Article
  4. Tepary Bean (International journal of molecular sciences · 2025
    Article
  5. Directed Mutagenesis for Arginine Substitution of aInternational journal of molecular sciences · 2024
    Article
  6. Article
  7. Polyphenols fromInternational journal of molecular sciences · 2024
    Article
  8. EGFR and p38Pharmaceuticals (Basel, Switzerland) · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Bioaccessibility andInternational journal of molecular sciences · 2021
    Article
  13. Article
  14. Protein Concentrates on Tepary Bean (Frontiers in nutrition · 2021
    Article
  15. Article
  16. Quantum Dot Labelling of Tepary Bean (Molecules (Basel, Switzerland) · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Ulisses Moreno-CelisFacultad de Ciencias Naturales, Universidad Autónoma de Querétaro, Av. de las Ciencias s/n. Juriquilla, Querétaro CP 76230, Mexico.ORCID 0000-0003-3751-6601
F Josué López-MartínezFacultad de Ciencias Naturales, Universidad Autónoma de Querétaro, Av. de las Ciencias s/n. Juriquilla, Querétaro CP 76230, Mexico.
Ricardo Cervantes-JiménezFacultad de Ciencias Naturales, Universidad Autónoma de Querétaro, Av. de las Ciencias s/n. Juriquilla, Querétaro CP 76230, Mexico.
Roberto Augusto Ferríz-MartínezFacultad de Ciencias Naturales, Universidad Autónoma de Querétaro, Av. de las Ciencias s/n. Juriquilla, Querétaro CP 76230, Mexico.ORCID 0000-0002-2495-6985
Alejandro Blanco-LabraDepto de Biotecnología y Bioquímica, Centro de Investigación y de estudios Avanzados del IPN-Unidad Irapuato, Guanajuato CP 36821, Mexico.
Teresa García-GascaFacultad de Ciencias Naturales, Universidad Autónoma de Querétaro, Av. de las Ciencias s/n. Juriquilla, Querétaro CP 76230, Mexico.ORCID 0000-0002-8793-9963
Autonomous University of Queretaro · MXInstituto Politécnico Nacional · MX

Funding

FOFI-UAQ s/n
6 · The paper itself

Abstract

A Tepary bean lectin fraction (TBLF) has been studied because it exhibits differential cytotoxic and anticancer effects on colon cancer. The present work focuses on the evaluation of the apoptotic mechanism of action on colon cancer cells. Initially, lethal concentrations (LC

Indexed as

ApoptosisCell Cycle CheckpointsCell Line, TumorCell ProliferationColonic NeoplasmsGene Expression Regulation, NeoplasticHT29 CellsHumansLectinsPhaseolusPhosphorylationProto-Oncogene Proteins c-bcl-2Signal TransductionTumor Suppressor Protein p53BCL2 protein, humanLectinsProto-Oncogene Proteins c-bcl-2TP53 protein, humanTumor Suppressor Protein p53apoptosis, colon cancer, lectins, p53, Phaseolus acutifolius

Identifiers

PMID32106533
PMCPMC7179131
OpenAlexW3006854092

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.